Studies consistently show that combining either drug with structured lifestyle support produces better results than medication alone
Thus, in addition to a comprehensive approach encompassing multidisciplinary risk factors (dyslipidaemia, hypertension, obesity, smoking, etc.) [8, 9], considering "what drugs to use to lower blood glucose" by selecting hypoglycaemic agents with evidence-based cardiorenal protective effects, according to patient background and risk status is increasingly important [10]
fumigatus ( Kim et al., 2012a)
Glycemic monitoring: For patients with type 2 diabetes, self-monitoring of blood glucose (SMBG) is particularly important during the first 12 weeks and during dose escalations
Because Wegovy lowers blood sugar levels, it may increase the risk of hypoglycemia (low blood sugar), especially when combined with other glucose-lowering medications like insulin in people with diabetes